Graminex L.L.C. Receives NNHPD Health Canada Approval for PollenBerry®

Graminex® L.L.C., producer of Graminex® Non-Solvent Flower Pollen Extracts™, receives Health Canada Approval under the Natural and Non-prescription Health Products Directorate (NNHPD) for its PollenBerry® Flower Pollen Extract™. PollenBerry® is a proprietary formulation containing Graminex® G60® Flower Pollen Extract™ and Cranberry Powder.

Health Canada’s certification guarantees that Graminex Products meet the highest quality standards according to the guidelines of Health Canada’s Health Products and Food Branch’s Mandate. The mandated guidelines take an integrated approach to managing the risks and benefits in regards to supplements and health food, safeguarding the consumer against inferior products.

“With the addition of PollenBerry®, Graminex® now has three finished goods approved by Health Canada’s NNHPD with the associated NPN numbers. We are happy to offer this newest product to our customers,” stated Justin E. Ritter, Regulatory Affairs.

PollenBerry® has been approved for use as a traditional and herbal medicine with Graminex’s newest NPN license. The recommended use for PollenBerry® approved under this NPN is to help prevent (recurrent) urinary tract infections (UTIs) in women. A secondary claim was approved to help prevent (recurrent) urinary tract infections, which may increase in frequency/incidence after/as a result of menopause in women.

Email This Post